Scientists from Arthritis Research Canada found a significant drop in all-cause mortality and major adverse cardiovascular events in people from the group who took glucagon-like peptide-1 receptor agonists.
Three people were treated in hospitals after trying the candies but were quickly discharged. The “revolting” taste led most who tried the sweets to immediately spit them out.
For those at high risk of diabetes, a threshold of four years of maintaining non-diabetic status could reduce the risk of death and cardiovascular complications.